Alisa B Ageenko

9PUBLICATIONS
21CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Sep 26, 2026
Whole-Transcriptome Profiling of Murine GL261 Glioma Reveals Signatures Consistent with Distinct Immune Reprogramming Induced by Oncolytic Virotherapy with VV-GMCSF-Lact and Anti-PD-1 Therapy.

|Mar 28, 2026
Oncolytic Virus VV-GMCSF-Lact and Human GM-CSF Against GL261 Glioma in Immunocompetent Mice.

Alisa B Ageenko, Natalia S Vasileva, Anna S Chesnokova

|Oct 28, 2025
Efficacy of Oncolytic Virus VV-GMCSF-Lact Against Immunocompetent Glioma.

Alisa Ageenko, Natalia Vasileva, Gaukhar Yusubalieva

|Jul 29, 2025
Single-Cell Transcriptomic Changes in Patient-Derived Glioma and U87 Glioblastoma Cell Cultures Infected with the Oncolytic Virus VV-GMCSF-Lact.

Dmitriy V Semenov, Natalia S Vasileva, Maxim E Menyailo

|Nov 27, 2024
Using Computer Modeling and Experimental Methods to Screen for Aptamers That Bind to the VV-GMCSF-LACT Virus.

Maya Dymova, Natalia Vasileva, Daria Malysheva

|Apr 27, 2024
The Recombinant Oncolytic Virus VV-GMCSF-Lact and Chemotherapy Drugs against Human Glioma.

Natalia Vasileva, Alisa Ageenko, Arina Byvakina

Pageof 2

Frequent Collaborators

9 joint publications

Natalia Vasileva

9 joint publications

Elena V Kuligina

6 joint publications

Maya Dymova

4 joint publications

Galina V Kochneva